The recently approved appropriations bill contains grant funds for psilocybin research.
Arizona senators voted to approve a general appropriations act 2023-2024 on May 10. Within the appropriations bill is a multitude of funding proposals from the governor’s office, which includes everything from Alzheimer’s disease research ($4.1 million), a newborn screening program ($12 million), and the Arizona nurse education investment pilot program ($15 million), but it also includes $5 million earmarked for psilocybin research.
A health care bill, SB-1726/HB-2816, recently receive a hearing on May 10 as well, which shows what that $5 million in research would go toward “research grants for whole mushroom psilocybin phase one, phase two and 41 phase three clinical trials that are capable of being approved by the 42 United States food and drug administration…” The bill cites a number of medical conditions, including PTSD, symptoms of long COVID-19, depression, anxiety disorders, and nine more.
If passed it would instruct the Department of Health Services to open up applications for research, which would be awarded no later than February 1 of each year. The department would be limited to spending a maximum of 2% of the money for psilocybin grant research each fiscal year.
Research subjects would specifically include “veterans, first responders, frontline health care workers … and persons from underserved communities.”
Protections are also included for both the grant receiver as well as any employees working on a study, stating that they “may not be charged with or prosecuted for possession … of psilocybin when the person is working on the clinical trial.”
A psilocybin research advisory council would be tasked to manage the program to provide “recommendations to the governor, the speaker of the House of Representatives, the president of the Senate and the department on psychedelic-assisted therapy based on current federal and state research policy.” It would be made up of multiple key individuals, including a member who holds a federal license to study psychedelics and is a licensed physician, a military veteran, an Arizona law enforcement officer, and a professor or researcher who specializes in psychedelic studies.
Read more at
Psilocybin Research Approved in Arizona Appropriations Act Budget
